Detalhe da pesquisa
1.
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial.
Lancet
; 401(10373): 294-302, 2023 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36709074
2.
A Monoclonal Antibody for Malaria Prevention.
N Engl J Med
; 385(9): 803-814, 2021 08 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34379916
3.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
N Engl J Med
; 383(25): 2427-2438, 2020 12 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32991794
4.
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
N Engl J Med
; 384(23): 2259-2261, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33822494
5.
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med
; 384(1): 80-82, 2021 01 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33270381
6.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37075129
7.
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
Nat Med
; 28(5): 1022-1030, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35411076
8.
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial.
EClinicalMedicine
; 48: 101477, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35783486
9.
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants.
bioRxiv
; 2021 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34031659
10.
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
Science
; 373(6556)2021 Aug 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34210892
11.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants.
bioRxiv
; 2021 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33655252
12.
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
Science
; 373(6561): 1372-1377, 2021 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-34385356